6th IAS Conference on HIV Pathogenesis, Treatment and Prevention held on July 17-20, 2011 at Rome, Italy

  1. Ubolyam S, Mahanontharit A, Chantarasuk Y, Likanonsakul S, Thongsuk P, Kasinrerk J, Teirsonsern P, Charoenthammachoke K, Ngo-Giang-Huong N, Sokheng C, Vonthanak S, Ussery M, Wetherall N, Puthanakit T, Ananworanich J, Ruxrungtham K, PREDICT Study Team. 5-year experience in Thailand of using CLIA and ISO to establish a laboratory network for US NIAID Pediatric Clinical Trials. [CD Rom Abstract # CDD278]
    http://pag.ias2011.org/EPosterHandler.axd?aid=3154
  2. Kosalaraksa P, Bunupuradah T, Apornpong T, Vibol U, Hansudewechakul R, Kanjanavanit S, Wongsawat J, Ngampiyaskul C, Luesomboon W, Mahanontharit A, Pinklow P, Puthanakit T, Ananworanich J, Vonthanak S, Ruxrungtham K on behalf of the PREDICT study team. Improved in iron status and anemia in HIV-infected children after zidovudine-containing HAART without routine iron supplementation. [poster # MOPE255]
    http://pag.ias2011.org/EPosterHandler.axd?aid=3424
    http://f1000.com/posters/view/document/1089312
  3. Chettra K, Puthanakit T, Apornpong T, Lumbiganon P, Vibol U, Hansudewechakul R, Kanjanavanit S, Wongsawat J, Ngampiyaskul C, Luesomboon W, Suwanlerk T, Intasan J, Vonthanak S, Ruxrungtham K on behalf of the PREDICT study team. Incidence and risk factors for nevirapine related toxicities among HIV-infected Asian children randomized to starting ART at different CD4%. [Poster # MOPE240]
    http://pag.ias2011.org/EPosterHandler.axd?aid=3248
    http://f1000.com/posters/view/document/1089267
  4. Puthanakit T, Vonthanak S, Ananworanich J, Kosaralaksa P, Hansudewechakul R, Vibol U , Kerr SJ, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Huong NN, Chettra K, Cheunyam T, Suwarnlerk T, Ubolyam S, Shearer WT, Paul R, Brouwers P, Mofenson L, Fox L, Law MG, Cooper DA, Phanuphak P, Vun MC, Ruxrungtham K on behalf of the PREDICT Study Group. Randomized clinical trial of immediate versus deferred antiretroviral therapy initiation in children older than one year with moderate immunodeficiency: The PREDICT Study (NCT00234091). [Poster # LBPE023; abstract # TULBPE023]
    http://pag.ias2011.org/EPosterHandler.axd?aid=4776
    http://f1000.com/posters/view/document/2149
    http://regist2.virology-education.com/2011/3 HIV ped/docs/41_Puthanakit.pdf